In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo.
暂无分享,去创建一个
Stephen Albert Johnston | S. Johnston | K. Brown | Kausar N Samli | Kathlynn C Brown | Michael J McGuire | M. Mcguire
[1] S. B. Needleman,et al. Protein Sequence Determination , 1975, Molecular Biology Biochemistry and Biophysics.
[2] Kit S Lam,et al. Therapeutic cancer targeting peptides. , 2002, Biopolymers.
[3] E. Ruoslahti. Targeting tumor vasculature with homing peptides from phage display. , 2000, Seminars in cancer biology.
[4] J. Wondergem,et al. Reirradiation tolerance of the rat heart. , 1996, International journal of radiation oncology, biology, physics.
[5] C. Granier,et al. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[6] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[7] T. Ikemura,et al. Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. , 1998, Gene.
[8] J. De Sutter,et al. The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] C. Buckley,et al. Identification of synovium-specific homing peptides by in vivo phage display selection. , 2002, Arthritis and rheumatism.
[10] N. Sinha,et al. The role of theophylline in contrast-induced nephropathy: a case-control study. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] P. Jones,et al. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[12] D. Lawlor,et al. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality , 2001, BMJ : British Medical Journal.
[13] Akira Takashima,et al. A library-selected, Langerhans cell-targeting peptide enhances an immune response. , 2004, DNA and cell biology.
[14] W. Arap,et al. Modulation of the immune response by systemic targeting of antigens to lymph nodes. , 2001, Cancer research.
[15] V. Vodyanoy,et al. Peptide biosensor for recognition of cross‐species cell surface markers , 2002, Journal of molecular recognition : JMR.
[16] Erkki Ruoslahti,et al. Targeting the prostate for destruction through a vascular address , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Barrett,et al. Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Tumlin,et al. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. , 2002, American heart journal.
[19] L. Kuller,et al. Coronary Heart Disease Mortality Among Men Aged 35-44 Years by Prefecture in Japan in 1995-1999 Compared With That Among White Men Aged 35-44 by State in the United States in 1995-1998 , 2001 .
[20] Stephen Albert Johnston,et al. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. , 2003, Cancer letters.
[21] A. Burnett,et al. Chemotherapy‐induced cardiotoxicity: current practice and prospects of prophylaxis , 2002, European journal of heart failure.
[22] L. Rutqvist,et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. , 1996, International journal of radiation oncology, biology, physics.
[23] P. Cohn. Treatment of Chronic Myocardial Ischemia: Rationale and Treatment Options , 1998, Cardiovascular Drugs and Therapy.
[24] Christopher Scarfone,et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. , 2003, Cancer cell.
[25] William J. Dower,et al. Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries , 1996, Nature Medicine.
[26] T. Ikemura,et al. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C , 1994, The Journal of cell biology.
[27] S. J. White,et al. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. , 2000, Circulation.
[28] M. Mevissen,et al. Structure, function and pharmacology of voltage-gated sodium channels , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[29] O. Dalesio,et al. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction , 2002, Nuclear medicine communications.
[30] B. Villari,et al. Acetylcysteine and contrast agent-associated nephrotoxicity. , 2002, Journal of the American College of Cardiology.
[31] Mouldy Sioud,et al. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] G. Källner,et al. Ion channels involved in the release of calcitonin gene-related peptide by low pH, prostacyclin and capsaicin in the isolated guinea-pig heart. , 1998, European journal of pharmacology.